Anti-SPPL-2B Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting SPPL-2B (signal peptide peptidase-like 2B), an intramembrane aspartic protease involved in TNFα and ITM2B cleavage.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
Q8TCT7
Size
100ug
Cat. #
RP4SPPL2B

In stock

SKU
RP-SPPL2B

Options

As low as: $130.00

Target Overview

Signal peptide peptidase-like 2B (SPPL2B, UniProt Q8TCT7) is a 592-amino acid intramembrane-cleaving aspartic protease (I-CLiP, EC 3.4.23.-) that catalyzes hydrolysis of type II membrane signal peptides within the hydrophobic plane of the membrane. Also designated intramembrane protease 4 (IMP-4) or presenilin homologous protein 4 (PSH4), SPPL2B is localized to the cell membrane and shares structural homology with presenilin family proteases. The enzyme cleaves a discrete set of substrates including tumor necrosis factor α (TNFα) and integral membrane protein 2B (ITM2B). Following ectodomain shedding of TNFα, SPPL2B catalyzes intramembrane cleavage of the membrane-anchored fragment, promoting release of the intracellular domain for nuclear signaling. SPPL2B also processes the simian foamy virus envelope glycoprotein gp130 leader peptide (gp18) following furin-mediated cleavage. This protease is implicated in regulation of innate and adaptive immunity and has emerged as a focus in studies of neurodegeneration and viral envelope processing.

Background

SPPL2B functions as a type II membrane signal peptide protease with substrate selectivity distinct from its paralog SPPL2A. Initial characterization demonstrated that SPPL2B catalyzes intramembrane cleavage of shed TNFα, generating an intracellular domain that translocates to the nucleus for downstream signaling. This activity positions SPPL2B as a modulator of inflammatory responses and immune regulation. Recent mechanistic studies have elucidated the role of N-terminal PA domains in determining substrate specificity; Schlosser et al (2025) demonstrated that these domains impact TNFα cleavage efficiency and substrate recognition. In vitro reconstitution experiments confirmed that SPPL2B-mediated TNFα cleavage follows mechanistic principles consistent with cellular observations, validating biochemical approaches to studying this enzyme. Beyond its established role in TNFα processing, SPPL2B has been implicated in neurodegenerative disease. Maccioni et al (2024) reported that SPPL2B modulates the amyloidogenic pathway and exhibits Aβ-dependent expression changes in Alzheimer's disease, suggesting cross-talk between intramembrane proteolysis pathways. SPPL2B also cleaves ITM2B, a protein associated with familial dementia, further linking this protease to neurological pathology. The enzyme's ability to process viral glycoproteins has implications for retroviral maturation and infectivity. Substrate identification continues to expand; Badman et al (2025) recently reviewed emerging substrates and disease connections, highlighting SPPL2B as a target of interest in inflammation, immunity, and neurodegeneration research. Triple Point Biologics offers four rabbit polyclonal antibodies targeting SPPL2B, raised against the first loop of the protein. These reagents are validated for Western blot, enabling investigation of SPPL2B expression, localization, and regulation across multiple experimental contexts.

References

  1. Badman J et al (2025) Insights into the intramembrane protease SPPL2b and its substrates: Functions and disease implications. Sci Signal. PubMed · DOI
  2. Schlosser C et al (2025) The N-terminal PA domains of signal-peptide-peptidase-like 2 (SPPL2) proteases impact on TNFα cleavage. Commun Biol. PubMed · DOI
  3. Sharrouf K et al (2024) In vitro cleavage of tumor necrosis factor α (TNFα) by Signal-Peptide-Peptidase-like 2b (SPPL2b) resembles mechanistic principles observed in the cellular context. Chem Biol Interact. PubMed · DOI
  4. Maccioni R et al (2024) Signal peptide peptidase-like 2b modulates the amyloidogenic pathway and exhibits an Aβ-dependent expression in Alzheimer's disease. Prog Neurobiol. PubMed · DOI

Additional Specifications

Size 100 µg
Gene Symbol SPPL2B
UniProt ID Q8TCT7
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (First loop)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 45-80.
Immunogen (Second loop)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 130-175.
Immunogen (Loop 6)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 420-470.
Immunogen (Carboxyterminal end long form)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 542-592.
Alternate Names SPPL2B, Signal peptide peptidase-like 2B, SPP-like 2B, SPPL2b, Intramembrane protease 4, IMP-4, Presenilin homologous protein 4, PSH4, Presenilin-like protein 1, EC 3.4.23.-

Frequently Asked Questions

What molecular weight should I expect for SPPL2B on a Western blot?

SPPL2B migrates at approximately 65-70 kDa on reducing SDS-PAGE, which corresponds to the full-length 592-amino acid protein (calculated MW ~67 kDa). Some researchers report bands slightly higher due to post-translational modifications. Because SPPL2B is an intramembrane protease, extraction with buffers containing 1% Triton X-100 or RIPA is necessary for efficient solubilization. If you observe multiple bands, consider that SPPL2B may undergo autoproteolysis or cleavage by related proteases in certain cell types. Always include a positive control lysate from SPPL2B-expressing cells to confirm band identity.

What is the recommended starting dilution for SPPL2B antibody in Western blot?

The validated dilution for this rabbit polyclonal SPPL2B antibody is 1:1000 in Western blot applications. This dilution has been tested against human samples and typically yields clean signal with minimal background when using standard chemiluminescent detection. Start at 1:1000 with overnight incubation at 4°C in 5% non-fat milk or BSA in TBST. If signal is weak in your lysate, you can titrate up to 1:500, though endogenous SPPL2B expression is often low in many cell types. Loading 30-50 µg total protein per lane is advisable for detecting this membrane protease.

Is SPPL2B expressed in all human tissues or only specific cell types?

SPPL2B shows restricted tissue expression compared to ubiquitous housekeeping genes. It is most abundant in immune cells, including B cells, dendritic cells, and macrophages, consistent with its role in processing TNFα and regulating immune signaling. Expression is also detected in heart, liver, and pancreas at moderate levels. Many immortalized cell lines express SPPL2B at low or undetectable levels, so selecting an appropriate positive control is critical. THP-1 monocytes, primary human PBMCs, or HEK293 cells transfected with SPPL2B expression plasmids serve as reliable positive controls for antibody validation experiments.

Does this antibody cross-react with SPPL2A or other family members?

SPPL2B shares significant sequence homology with SPPL2A (approximately 60% identity), SPPL2C, and SPPL3, raising the possibility of cross-reactivity. This antibody has been validated specifically for human SPPL2B, but cross-reactivity with closely related family members has not been formally ruled out. If you are working in systems where multiple SPPL family members are co-expressed, consider including siRNA or CRISPR knockdown controls to confirm band identity. The unique substrate specificity and tissue distribution of SPPL2B compared to SPPL2A can also provide functional context, but orthogonal validation is advisable for critical experiments.

What sample preparation method works best for detecting the intramembrane protease SPPL2B?

Because SPPL2B is an intramembrane-cleaving protease embedded in the lipid bilayer, effective solubilization requires detergent-containing lysis buffers. RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS) efficiently extracts SPPL2B from membranes while preserving epitope recognition. Avoid mild lysis conditions such as hypotonic buffers without detergent, which leave membrane proteins in the insoluble pellet. Sonication or freeze-thaw cycles after lysis can improve yield. For immunofluorescence or IHC applications, methanol or methanol-acetone fixation preserves membrane protein antigenicity better than formaldehyde alone, though formaldehyde-fixed paraffin-embedded sections can work with antigen retrieval.

Can this SPPL2B antibody be used in mouse or rat samples?

This antibody has been validated in human samples, and cross-reactivity with mouse or rat SPPL2B is predicted but not experimentally confirmed. Human and mouse SPPL2B share approximately 85% sequence identity, suggesting the epitope may be conserved. If you plan to use mouse or rat lysates, treat this as an optimization experiment: start at 1:1000 dilution and include a positive control such as transfected lysate or tissue known to express SPPL2B (spleen, thymus). Compare migration patterns and consider orthogonal validation with a second antibody or RT-qPCR to confirm specificity before relying on results for publication.

How should I store this SPPL2B antibody and what is the expected shelf life?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100 µg pack size is sufficient for 100 Western blots at 1:1000 dilution (assuming 1 ml blocking volume per blot). After reconstitution or first thaw, aliquot into 10-20 µl volumes and store at -20°C for up to 12 months. For long-term storage beyond one year, -80°C is preferable. Add 0.02% sodium azide or 50% glycerol as a preservative if you anticipate extended storage periods. Avoid storing diluted antibody in working solutions; prepare fresh dilutions for each experiment.

What controls should I include when validating SPPL2B antibody signal specificity?

Include both positive and negative controls to confirm specificity. A positive control might be lysate from THP-1 cells, human PBMCs, or HEK293 cells transiently transfected with SPPL2B expression plasmid. For a negative control, use lysate from cells in which SPPL2B has been knocked down via siRNA or knocked out by CRISPR; signal should be absent or dramatically reduced. Peptide competition assays with the immunizing peptide can further validate specificity, though this reagent may need to be requested separately. Finally, comparing signal across multiple cell types with known differential SPPL2B expression (high in immune cells, low in fibroblasts) provides biological plausibility.

Validation imagery coming soon

Western blot validation figures for RP-SPPL2B will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • SPPL2B
  • Signal peptide peptidase-like 2B
  • SPP-like 2B
  • SPPL2b
  • Intramembrane protease 4
  • IMP-4
  • Presenilin homologous protein 4
  • PSH4
  • Presenilin-like protein 1
  • EC 3.4.23.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →